Israel - English - Ministry of Health

inovamed pharma ltd, israel - ertapenem as monosodium - lyophilized powder for injection - ertapenem as monosodium 1 g/vial - ertapenem - ertapemed is indicated for the treatment of adult patients and pediatric patients (3 months of age and older) with the following moderate to severe infections caused by susceptible isolates of the designated microorganisms. - complicated intra-abdominal infections. - complicated skin and skin structure infections including diabetic foot infections without osteomyelitis. - community acquired pneumonia. - complicated urinary tract infections including pyelonephritis. acute pelvic infections including postpartum endomyometritis, septic abortion and post surgical gynecologic infections

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sodium valproate, quantity: 40 mg/ml - oral liquid - excipient ingredients: sorbitol; sodium propyl hydroxybenzoate; sodium methyl hydroxybenzoate; saccharin sodium; brilliant scarlet 4r; purified water; sucrose; flavour - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

fresenius kabi ltd - ertapenem sodium - powder for solution for infusion - 1gram

Singapore - English - HSA (Health Sciences Authority)

novem pharma private limited - ertapenem sodium 1.046 g eqv to ertapenem - injection, powder, lyophilized, for solution - ertapenem sodium 1.046 g eqv to ertapenem 1 g

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

panpharma uk ltd - ertapenem sodium - powder for solution for infusion - 1gram

Kenya - English - Pharmacy and Poisons Board

ertapenem sodium 1.046g eq. to ertapenem 1g - injection - ertapenem sodium 1.046g eq. to ertapenem 1g - ertapenem

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fresenius kabi malaysia sdn. bhd - ertapenem sodium -

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sodium valproate 100mg - tablet - 100 mg - active: sodium valproate 100mg excipient: hydrated silica light kaolin magnesium stearate maize starch purified water - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - sodium valproate 199.8mg; valproic acid 87mg (as navalproate 100.3mg) - modified release tablet - 300 mg - active: sodium valproate 199.8mg valproic acid 87mg (as navalproate 100.3mg) excipient: erythrosine ethylcellulose hydrated silica hypromellose   indigo carmine iron oxide black propylene glycol purified water titanium dioxide - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sodium valproate 400mg - powder for injection with diluent - 100 mg/ml - active: sodium valproate 400mg excipient: water for injection - epilim iv: the treatment of patients with epilepsy or bipolar disorder, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.